Millions of Americans with obesity could soon gain access to popular weight-loss drugs including Wegovy and Ozempic through Medicare and Medicaid under a new proposal from the Biden administration. Announced Tuesday by the Department of Health and Human Services (HHS), the rule aims to make these costly medications available to a broader population, sparking a contentious debate about its potential affect. The drugs, heralded by some as miracle treatments, help...